---  
layout: startup_page  
title: "Vivace Therapeutics"  
id: "vivacetherapeutics.com"  
permalink: "/vivacetherapeuticsvivacetherapeutics.com03122025/"  
website: "http://www.vivacetherapeutics.com/"  
funding_round: "Series D"  
funding_amount: "$35M"  
investors: "RA Capital Management, Canaan Partners, Cenova Capital"  
about: "Vivace Therapeutics is a small molecule drug discovery and development company focusing on targeting the Hippo pathway to treat human carcinomas. Their lead product, VT3989, is a first-in-class TEAD autopalmitoylation inhibitor showing promising results in mesothelioma patients. The company is advancing VT3989 toward a registrational Phase 3 clinical trial."  
markets: "Biotech, Oncology, Therapeutics"  
hq: "San Mateo, California, United States"  
founded_year: "2014"  
linkedin: "https://www.linkedin.com/company/vivace-therapeutics-inc-"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/vivace-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/107318-89"  

date_display: "12-Mar-2025"  
date: "2025-03-12"

# SEO Optimization  
meta_title: "Vivace Therapeutics - Series D Funding ($35M)"  
meta_description: "Vivace Therapeutics, Vivace Therapeutics is a small molecule drug discovery and development company focusing on targeting the Hippo pathway to treat human carcinomas. Thei..."  
meta_keywords: "Vivace Therapeutics, Biotech, Oncology, Therapeutics, Series D funding"  
canonical_url: "https://startup.projectstartups.com/vivacetherapeuticsvivacetherapeutics.com03122025/"  
---